世界の冠動脈疾患治療薬市場インサイト及び予測(~2026年)

【英語タイトル】Global Coronary Artery Disease Therapeutics Market Size, Status and Forecast 2020-2026

QYResearchが出版した調査資料(QYR20NV11510)・商品コード:QYR20NV11510
・発行会社(調査会社):QYResearch
・発行日:2020年11月(※2024年版があります。お問い合わせください)
・ページ数:91
・レポート言語:英語
・レポート形式:PDF
・納品方法:Eメール(受注後3営業日)
・調査対象地域:グローバル
・産業分野:ヘルスケア
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD3,900 ⇒換算¥577,200見積依頼/購入/質問フォーム
Multi User(5名様閲覧用)USD5,850 ⇒換算¥865,800見積依頼/購入/質問フォーム
Enterprise License(同一法人内共有可)USD7,800 ⇒換算¥1,154,400見積依頼/購入/質問フォーム
販売価格オプションの説明
※お支払金額:換算金額(日本円)+消費税
※納期:即日〜2営業日(3日以上かかる場合は別途表記又はご連絡)
※お支払方法:納品日+5日以内に請求書を発行・郵送(請求書発行日より2ヶ月以内に銀行振込、振込先:三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能)
本調査レポートは冠動脈疾患治療薬の世界市場について調査・分析した資料です。種類別(ベータ遮断薬、カルシウムチャネル遮断薬、硝酸塩、ACE阻害薬、その他)の市場規模、用途別(病院、クリニック、その他)の市場規模、地域別(北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等)の市場規模データ、主な企業情報と企業別市場シェア等が記載されています。
・調査範囲
・エグゼクティブサマリー
・企業別冠動脈疾患治療薬の競争状況、市場シェア
・世界の冠動脈疾患治療薬市場:種類別市場規模 2015年-2020年(ベータ遮断薬、カルシウムチャネル遮断薬、硝酸塩、ACE阻害薬、その他)
・世界の冠動脈疾患治療薬市場:種類別市場規模予測 2021年-2026年(ベータ遮断薬、カルシウムチャネル遮断薬、硝酸塩、ACE阻害薬、その他)
・世界の冠動脈疾患治療薬市場:用途別市場規模 2015年-2020年(病院、クリニック、その他)
・世界の冠動脈疾患治療薬市場:用途別市場規模予測 2021年-2026年(病院、クリニック、その他)
・北米の冠動脈疾患治療薬市場分析:米国、カナダ
・ヨーロッパの冠動脈疾患治療薬市場分析:ドイツ、フランス、イギリス、イタリア、ロシア等
・アジアの冠動脈疾患治療薬市場分析:日本、中国、韓国、インド、オーストラリア、台湾等
・中南米の冠動脈疾患治療薬市場分析:メキシコ、ブラジル、アルゼンチン等
・中東・アフリカの冠動脈疾患治療薬市場分析:トルコ、サウジアラビア、UAE等
・企業情報(企業概要、製品概要、販売量、企業動向)
- 掲載企業(変更可能性あり):Pfizer、Novartis、GlaxoSmithKline、Merck、AstraZeneca、Gilead、Bayer、Bristol-Myers Squibb、Mylan、Teva Pharmaceutical Industries
・地域別市場規模予測(2021年-2026年):北米市場、ヨーロッパ市場、アジア市場、中南米市場、中東・アフリカ市場
・市場機会、課題、リスク、環境分析
・バリューチェーン、販売チャネル分析
・調査の結論
【レポートの概要】

Coronary artery disease (CAD), also known as ischemic heart disease (IHD), refers to a group of diseases which includes stable angina, unstable angina, myocardial infarction, and sudden cardiac death.
Our research analysis on the global coronary artery disease therapeutics market has identified that the increase in number of chronic diseases will be one of the major factors that will have a positive impact on this market’s growth during the next few years.

Market Analysis and Insights: Global Coronary Artery Disease Therapeutics Market
The global Coronary Artery Disease Therapeutics market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026.

Global Coronary Artery Disease Therapeutics Scope and Market Size
Coronary Artery Disease Therapeutics market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Coronary Artery Disease Therapeutics market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.

The key players covered in this study
Pfizer
Novartis
GlaxoSmithKline
Merck
AstraZeneca
Gilead
Bayer
Bristol-Myers Squibb
Mylan
Teva Pharmaceutical Industries

Market segment by Type, the product can be split into
Beta-Blockers
Calcium Channel Blockers
Nitrates
ACE Inhibitors
Others
Market segment by Application, split into
Hospitals
Clinics
Others

Market segment by Regions/Countries, this report covers
North America
Europe
China
Japan
Southeast Asia
India

【レポートの目次】

1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Coronary Artery Disease Therapeutics Revenue
1.4 Market by Type
1.4.1 Global Coronary Artery Disease Therapeutics Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 Beta-Blockers
1.4.3 Calcium Channel Blockers
1.4.4 Nitrates
1.4.5 ACE Inhibitors
1.4.6 Others
1.5 Market by Application
1.5.1 Global Coronary Artery Disease Therapeutics Market Share by Application: 2020 VS 2026
1.5.2 Hospitals
1.5.3 Clinics
1.5.4 Others
1.6 Study Objectives
1.7 Years Considered

2 Global Growth Trends
2.1 Global Coronary Artery Disease Therapeutics Market Perspective (2015-2026)
2.2 Global Coronary Artery Disease Therapeutics Growth Trends by Regions
2.2.1 Coronary Artery Disease Therapeutics Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Coronary Artery Disease Therapeutics Historic Market Share by Regions (2015-2020)
2.2.3 Coronary Artery Disease Therapeutics Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter’s Five Forces Analysis
2.3.5 Coronary Artery Disease Therapeutics Market Growth Strategy
2.3.6 Primary Interviews with Key Coronary Artery Disease Therapeutics Players (Opinion Leaders)

3 Competition Landscape by Key Players
3.1 Global Top Coronary Artery Disease Therapeutics Players by Market Size
3.1.1 Global Top Coronary Artery Disease Therapeutics Players by Revenue (2015-2020)
3.1.2 Global Coronary Artery Disease Therapeutics Revenue Market Share by Players (2015-2020)
3.1.3 Global Coronary Artery Disease Therapeutics Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Coronary Artery Disease Therapeutics Market Concentration Ratio
3.2.1 Global Coronary Artery Disease Therapeutics Market Concentration Ratio (CR5 and HHI)
3.2.2 Global Top 10 and Top 5 Companies by Coronary Artery Disease Therapeutics Revenue in 2019
3.3 Coronary Artery Disease Therapeutics Key Players Head office and Area Served
3.4 Key Players Coronary Artery Disease Therapeutics Product Solution and Service
3.5 Date of Enter into Coronary Artery Disease Therapeutics Market
3.6 Mergers & Acquisitions, Expansion Plans

4 Market Size by Type (2015-2026)
4.1 Global Coronary Artery Disease Therapeutics Historic Market Size by Type (2015-2020)
4.2 Global Coronary Artery Disease Therapeutics Forecasted Market Size by Type (2021-2026)

5 Market Size by Application (2015-2026)
5.1 Global Coronary Artery Disease Therapeutics Market Size by Application (2015-2020)
5.2 Global Coronary Artery Disease Therapeutics Forecasted Market Size by Application (2021-2026)

6 North America
6.1 North America Coronary Artery Disease Therapeutics Market Size (2015-2020)
6.2 Coronary Artery Disease Therapeutics Key Players in North America (2019-2020)
6.3 North America Coronary Artery Disease Therapeutics Market Size by Type (2015-2020)
6.4 North America Coronary Artery Disease Therapeutics Market Size by Application (2015-2020)

7 Europe
7.1 Europe Coronary Artery Disease Therapeutics Market Size (2015-2020)
7.2 Coronary Artery Disease Therapeutics Key Players in Europe (2019-2020)
7.3 Europe Coronary Artery Disease Therapeutics Market Size by Type (2015-2020)
7.4 Europe Coronary Artery Disease Therapeutics Market Size by Application (2015-2020)

8 China
8.1 China Coronary Artery Disease Therapeutics Market Size (2015-2020)
8.2 Coronary Artery Disease Therapeutics Key Players in China (2019-2020)
8.3 China Coronary Artery Disease Therapeutics Market Size by Type (2015-2020)
8.4 China Coronary Artery Disease Therapeutics Market Size by Application (2015-2020)

9 Japan
9.1 Japan Coronary Artery Disease Therapeutics Market Size (2015-2020)
9.2 Coronary Artery Disease Therapeutics Key Players in Japan (2019-2020)
9.3 Japan Coronary Artery Disease Therapeutics Market Size by Type (2015-2020)
9.4 Japan Coronary Artery Disease Therapeutics Market Size by Application (2015-2020)

10 Southeast Asia
10.1 Southeast Asia Coronary Artery Disease Therapeutics Market Size (2015-2020)
10.2 Coronary Artery Disease Therapeutics Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Coronary Artery Disease Therapeutics Market Size by Type (2015-2020)
10.4 Southeast Asia Coronary Artery Disease Therapeutics Market Size by Application (2015-2020)

11 India
11.1 India Coronary Artery Disease Therapeutics Market Size (2015-2020)
11.2 Coronary Artery Disease Therapeutics Key Players in India (2019-2020)
11.3 India Coronary Artery Disease Therapeutics Market Size by Type (2015-2020)
11.4 India Coronary Artery Disease Therapeutics Market Size by Application (2015-2020)

12 Central & South America
12.1 Central & South America Coronary Artery Disease Therapeutics Market Size (2015-2020)
12.2 Coronary Artery Disease Therapeutics Key Players in Central & South America (2019-2020)
12.3 Central & South America Coronary Artery Disease Therapeutics Market Size by Type (2015-2020)
12.4 Central & South America Coronary Artery Disease Therapeutics Market Size by Application (2015-2020)

13 Key Players Profiles
13.1 Pfizer
13.1.1 Pfizer Company Details
13.1.2 Pfizer Business Overview
13.1.3 Pfizer Coronary Artery Disease Therapeutics Introduction
13.1.4 Pfizer Revenue in Coronary Artery Disease Therapeutics Business (2015-2020))
13.1.5 Pfizer Recent Development
13.2 Novartis
13.2.1 Novartis Company Details
13.2.2 Novartis Business Overview
13.2.3 Novartis Coronary Artery Disease Therapeutics Introduction
13.2.4 Novartis Revenue in Coronary Artery Disease Therapeutics Business (2015-2020)
13.2.5 Novartis Recent Development
13.3 GlaxoSmithKline
13.3.1 GlaxoSmithKline Company Details
13.3.2 GlaxoSmithKline Business Overview
13.3.3 GlaxoSmithKline Coronary Artery Disease Therapeutics Introduction
13.3.4 GlaxoSmithKline Revenue in Coronary Artery Disease Therapeutics Business (2015-2020)
13.3.5 GlaxoSmithKline Recent Development
13.4 Merck
13.4.1 Merck Company Details
13.4.2 Merck Business Overview
13.4.3 Merck Coronary Artery Disease Therapeutics Introduction
13.4.4 Merck Revenue in Coronary Artery Disease Therapeutics Business (2015-2020)
13.4.5 Merck Recent Development
13.5 AstraZeneca
13.5.1 AstraZeneca Company Details
13.5.2 AstraZeneca Business Overview
13.5.3 AstraZeneca Coronary Artery Disease Therapeutics Introduction
13.5.4 AstraZeneca Revenue in Coronary Artery Disease Therapeutics Business (2015-2020)
13.5.5 AstraZeneca Recent Development
13.6 Gilead
13.6.1 Gilead Company Details
13.6.2 Gilead Business Overview
13.6.3 Gilead Coronary Artery Disease Therapeutics Introduction
13.6.4 Gilead Revenue in Coronary Artery Disease Therapeutics Business (2015-2020)
13.6.5 Gilead Recent Development
13.7 Bayer
13.7.1 Bayer Company Details
13.7.2 Bayer Business Overview
13.7.3 Bayer Coronary Artery Disease Therapeutics Introduction
13.7.4 Bayer Revenue in Coronary Artery Disease Therapeutics Business (2015-2020)
13.7.5 Bayer Recent Development
13.8 Bristol-Myers Squibb
13.8.1 Bristol-Myers Squibb Company Details
13.8.2 Bristol-Myers Squibb Business Overview
13.8.3 Bristol-Myers Squibb Coronary Artery Disease Therapeutics Introduction
13.8.4 Bristol-Myers Squibb Revenue in Coronary Artery Disease Therapeutics Business (2015-2020)
13.8.5 Bristol-Myers Squibb Recent Development
13.9 Mylan
13.9.1 Mylan Company Details
13.9.2 Mylan Business Overview
13.9.3 Mylan Coronary Artery Disease Therapeutics Introduction
13.9.4 Mylan Revenue in Coronary Artery Disease Therapeutics Business (2015-2020)
13.9.5 Mylan Recent Development
13.10 Teva Pharmaceutical Industries
13.10.1 Teva Pharmaceutical Industries Company Details
13.10.2 Teva Pharmaceutical Industries Business Overview
13.10.3 Teva Pharmaceutical Industries Coronary Artery Disease Therapeutics Introduction
13.10.4 Teva Pharmaceutical Industries Revenue in Coronary Artery Disease Therapeutics Business (2015-2020)
13.10.5 Teva Pharmaceutical Industries Recent Development

14 Analyst’s Viewpoints/Conclusions

15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details

List of Tables
Table 1. Coronary Artery Disease Therapeutics Key Market Segments
Table 2. Key Players Covered: Ranking by Coronary Artery Disease Therapeutics Revenue
Table 3. Ranking of Global Top Coronary Artery Disease Therapeutics Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Coronary Artery Disease Therapeutics Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of Beta-Blockers
Table 6. Key Players of Calcium Channel Blockers
Table 7. Key Players of Nitrates
Table 8. Key Players of ACE Inhibitors
Table 9. Key Players of Others
Table 10. Global Coronary Artery Disease Therapeutics Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 11. Global Coronary Artery Disease Therapeutics Market Size by Regions (US$ Million): 2020 VS 2026
Table 12. Global Coronary Artery Disease Therapeutics Market Size by Regions (2015-2020) (US$ Million)
Table 13. Global Coronary Artery Disease Therapeutics Market Share by Regions (2015-2020)
Table 14. Global Coronary Artery Disease Therapeutics Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 15. Global Coronary Artery Disease Therapeutics Market Share by Regions (2021-2026)
Table 16. Market Top Trends
Table 17. Key Drivers: Impact Analysis
Table 18. Key Challenges
Table 19. Coronary Artery Disease Therapeutics Market Growth Strategy
Table 20. Main Points Interviewed from Key Coronary Artery Disease Therapeutics Players
Table 21. Global Coronary Artery Disease Therapeutics Revenue by Players (2015-2020) (Million US$)
Table 22. Global Coronary Artery Disease Therapeutics Market Share by Players (2015-2020)
Table 23. Global Top Coronary Artery Disease Therapeutics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Coronary Artery Disease Therapeutics as of 2019)
Table 24. Global Coronary Artery Disease Therapeutics by Players Market Concentration Ratio (CR5 and HHI)
Table 25. Key Players Headquarters and Area Served
Table 26. Key Players Coronary Artery Disease Therapeutics Product Solution and Service
Table 27. Date of Enter into Coronary Artery Disease Therapeutics Market
Table 28. Mergers & Acquisitions, Expansion Plans
Table 29. Global Coronary Artery Disease Therapeutics Market Size by Type (2015-2020) (Million US$)
Table 30. Global Coronary Artery Disease Therapeutics Market Size Share by Type (2015-2020)
Table 31. Global Coronary Artery Disease Therapeutics Revenue Market Share by Type (2021-2026)
Table 32. Global Coronary Artery Disease Therapeutics Market Size Share by Application (2015-2020)
Table 33. Global Coronary Artery Disease Therapeutics Market Size by Application (2015-2020) (Million US$)
Table 34. Global Coronary Artery Disease Therapeutics Market Size Share by Application (2021-2026)
Table 35. North America Key Players Coronary Artery Disease Therapeutics Revenue (2019-2020) (Million US$)
Table 36. North America Key Players Coronary Artery Disease Therapeutics Market Share (2019-2020)
Table 37. North America Coronary Artery Disease Therapeutics Market Size by Type (2015-2020) (Million US$)
Table 38. North America Coronary Artery Disease Therapeutics Market Share by Type (2015-2020)
Table 39. North America Coronary Artery Disease Therapeutics Market Size by Application (2015-2020) (Million US$)
Table 40. North America Coronary Artery Disease Therapeutics Market Share by Application (2015-2020)
Table 41. Europe Key Players Coronary Artery Disease Therapeutics Revenue (2019-2020) (Million US$)
Table 42. Europe Key Players Coronary Artery Disease Therapeutics Market Share (2019-2020)
Table 43. Europe Coronary Artery Disease Therapeutics Market Size by Type (2015-2020) (Million US$)
Table 44. Europe Coronary Artery Disease Therapeutics Market Share by Type (2015-2020)
Table 45. Europe Coronary Artery Disease Therapeutics Market Size by Application (2015-2020) (Million US$)
Table 46. Europe Coronary Artery Disease Therapeutics Market Share by Application (2015-2020)
Table 47. China Key Players Coronary Artery Disease Therapeutics Revenue (2019-2020) (Million US$)
Table 48. China Key Players Coronary Artery Disease Therapeutics Market Share (2019-2020)
Table 49. China Coronary Artery Disease Therapeutics Market Size by Type (2015-2020) (Million US$)
Table 50. China Coronary Artery Disease Therapeutics Market Share by Type (2015-2020)
Table 51. China Coronary Artery Disease Therapeutics Market Size by Application (2015-2020) (Million US$)
Table 52. China Coronary Artery Disease Therapeutics Market Share by Application (2015-2020)
Table 53. Japan Key Players Coronary Artery Disease Therapeutics Revenue (2019-2020) (Million US$)
Table 54. Japan Key Players Coronary Artery Disease Therapeutics Market Share (2019-2020)
Table 55. Japan Coronary Artery Disease Therapeutics Market Size by Type (2015-2020) (Million US$)
Table 56. Japan Coronary Artery Disease Therapeutics Market Share by Type (2015-2020)
Table 57. Japan Coronary Artery Disease Therapeutics Market Size by Application (2015-2020) (Million US$)
Table 58. Japan Coronary Artery Disease Therapeutics Market Share by Application (2015-2020)
Table 59. Southeast Asia Key Players Coronary Artery Disease Therapeutics Revenue (2019-2020) (Million US$)
Table 60. Southeast Asia Key Players Coronary Artery Disease Therapeutics Market Share (2019-2020)
Table 61. Southeast Asia Coronary Artery Disease Therapeutics Market Size by Type (2015-2020) (Million US$)
Table 62. Southeast Asia Coronary Artery Disease Therapeutics Market Share by Type (2015-2020)
Table 63. Southeast Asia Coronary Artery Disease Therapeutics Market Size by Application (2015-2020) (Million US$)
Table 64. Southeast Asia Coronary Artery Disease Therapeutics Market Share by Application (2015-2020)
Table 65. India Key Players Coronary Artery Disease Therapeutics Revenue (2019-2020) (Million US$)
Table 66. India Key Players Coronary Artery Disease Therapeutics Market Share (2019-2020)
Table 67. India Coronary Artery Disease Therapeutics Market Size by Type (2015-2020) (Million US$)
Table 68. India Coronary Artery Disease Therapeutics Market Share by Type (2015-2020)
Table 69. India Coronary Artery Disease Therapeutics Market Size by Application (2015-2020) (Million US$)
Table 70. India Coronary Artery Disease Therapeutics Market Share by Application (2015-2020)
Table 71. Central & South America Key Players Coronary Artery Disease Therapeutics Revenue (2019-2020) (Million US$)
Table 72. Central & South America Key Players Coronary Artery Disease Therapeutics Market Share (2019-2020)
Table 73. Central & South America Coronary Artery Disease Therapeutics Market Size by Type (2015-2020) (Million US$)
Table 74. Central & South America Coronary Artery Disease Therapeutics Market Share by Type (2015-2020)
Table 75. Central & South America Coronary Artery Disease Therapeutics Market Size by Application (2015-2020) (Million US$)
Table 76. Central & South America Coronary Artery Disease Therapeutics Market Share by Application (2015-2020)
Table 77. Pfizer Company Details
Table 78. Pfizer Business Overview
Table 79. Pfizer Product
Table 80. Pfizer Revenue in Coronary Artery Disease Therapeutics Business (2015-2020) (Million US$)
Table 81. Pfizer Recent Development
Table 82. Novartis Company Details
Table 83. Novartis Business Overview
Table 84. Novartis Product
Table 85. Novartis Revenue in Coronary Artery Disease Therapeutics Business (2015-2020) (Million US$)
Table 86. Novartis Recent Development
Table 87. GlaxoSmithKline Company Details
Table 88. GlaxoSmithKline Business Overview
Table 89. GlaxoSmithKline Product
Table 90. GlaxoSmithKline Revenue in Coronary Artery Disease Therapeutics Business (2015-2020) (Million US$)
Table 91. GlaxoSmithKline Recent Development
Table 92. Merck Company Details
Table 93. Merck Business Overview
Table 94. Merck Product
Table 95. Merck Revenue in Coronary Artery Disease Therapeutics Business (2015-2020) (Million US$)
Table 96. Merck Recent Development
Table 97. AstraZeneca Company Details
Table 98. AstraZeneca Business Overview
Table 99. AstraZeneca Product
Table 100. AstraZeneca Revenue in Coronary Artery Disease Therapeutics Business (2015-2020) (Million US$)
Table 101. AstraZeneca Recent Development
Table 102. Gilead Company Details
Table 103. Gilead Business Overview
Table 104. Gilead Product
Table 105. Gilead Revenue in Coronary Artery Disease Therapeutics Business (2015-2020) (Million US$)
Table 106. Gilead Recent Development
Table 107. Bayer Company Details
Table 108. Bayer Business Overview
Table 109. Bayer Product
Table 110. Bayer Revenue in Coronary Artery Disease Therapeutics Business (2015-2020) (Million US$)
Table 111. Bayer Recent Development
Table 112. Bristol-Myers Squibb Business Overview
Table 113. Bristol-Myers Squibb Product
Table 114. Bristol-Myers Squibb Company Details
Table 115. Bristol-Myers Squibb Revenue in Coronary Artery Disease Therapeutics Business (2015-2020) (Million US$)
Table 116. Bristol-Myers Squibb Recent Development
Table 117. Mylan Company Details
Table 118. Mylan Business Overview
Table 119. Mylan Product
Table 120. Mylan Revenue in Coronary Artery Disease Therapeutics Business (2015-2020) (Million US$)
Table 121. Mylan Recent Development
Table 122. Teva Pharmaceutical Industries Company Details
Table 123. Teva Pharmaceutical Industries Business Overview
Table 124. Teva Pharmaceutical Industries Product
Table 125. Teva Pharmaceutical Industries Revenue in Coronary Artery Disease Therapeutics Business (2015-2020) (Million US$)
Table 126. Teva Pharmaceutical Industries Recent Development
Table 127. Research Programs/Design for This Report
Table 128. Key Data Information from Secondary Sources
Table 129. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Coronary Artery Disease Therapeutics Market Share by Type: 2020 VS 2026
Figure 2. Beta-Blockers Features
Figure 3. Calcium Channel Blockers Features
Figure 4. Nitrates Features
Figure 5. ACE Inhibitors Features
Figure 6. Others Features
Figure 7. Global Coronary Artery Disease Therapeutics Market Share by Application: 2020 VS 2026
Figure 8. Hospitals Case Studies
Figure 9. Clinics Case Studies
Figure 10. Others Case Studies
Figure 11. Coronary Artery Disease Therapeutics Report Years Considered
Figure 12. Global Coronary Artery Disease Therapeutics Market Size YoY Growth 2015-2026 (US$ Million)
Figure 13. Global Coronary Artery Disease Therapeutics Market Share by Regions: 2020 VS 2026
Figure 14. Global Coronary Artery Disease Therapeutics Market Share by Regions (2021-2026)
Figure 15. Porter's Five Forces Analysis
Figure 16. Global Coronary Artery Disease Therapeutics Market Share by Players in 2019
Figure 17. Global Top Coronary Artery Disease Therapeutics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Coronary Artery Disease Therapeutics as of 2019
Figure 18. The Top 10 and 5 Players Market Share by Coronary Artery Disease Therapeutics Revenue in 2019
Figure 19. North America Coronary Artery Disease Therapeutics Market Size YoY Growth (2015-2020) (Million US$)
Figure 20. Europe Coronary Artery Disease Therapeutics Market Size YoY Growth (2015-2020) (Million US$)
Figure 21. China Coronary Artery Disease Therapeutics Market Size YoY Growth (2015-2020) (Million US$)
Figure 22. Japan Coronary Artery Disease Therapeutics Market Size YoY Growth (2015-2020) (Million US$)
Figure 23. Southeast Asia Coronary Artery Disease Therapeutics Market Size YoY Growth (2015-2020) (Million US$)
Figure 24. India Coronary Artery Disease Therapeutics Market Size YoY Growth (2015-2020) (Million US$)
Figure 25. Central & South America Coronary Artery Disease Therapeutics Market Size YoY Growth (2015-2020) (Million US$)
Figure 26. Bottom-up and Top-down Approaches for This Report
Figure 27. Data Triangulation
Figure 28. Key Executives Interviewed


【掲載企業】

Pfizer、Novartis、GlaxoSmithKline、Merck、AstraZeneca、Gilead、Bayer、Bristol-Myers Squibb、Mylan、Teva Pharmaceutical Industries

★調査レポート[世界の冠動脈疾患治療薬市場インサイト及び予測(~2026年)] (コード:QYR20NV11510)販売に関する免責事項を必ずご確認ください。
★調査レポート[世界の冠動脈疾患治療薬市場インサイト及び予測(~2026年)]についてメールでお問い合わせ


◆H&Iグローバルリサーチのお客様(例)◆